As from August 10, 2017, subscription rights issued by ExpreS2ion Biotech Holding AB will be traded on First North. Trading will continue until August 22, 2017.
| Instrument: | Subscription rights |
| Short name: | EXPRS2 TR |
| Round lot: | 1 |
| ISIN code: | SE0010219915 |
| Orderbook ID: | 142292 |
| Market Segment: | First North STO / 8 |
| Tick size Table: | Other Equities / 227 |
| Mic Code: | FNSE |
As from August 10, 2017, paid subscription shares issued by ExpreS2ion Biotech Holding AB will be traded on First North. Trading will continue until further notice.
| Instrument: | Paid subscription shares |
| Short name: | EXPRS2 BTA |
| Round lot: | 1 |
| ISIN code: | SE0010219923 |
| Orderbook ID: | 142293 |
| Market Segment: | First North STO / 8 |
| Tick size Table: | Other Equities / 227 |
| Mic Code: | FNSE |
This information is distributed at the request of the Certified Adviser, Sedermera Fondkommission. For further information, please call Sedermera Fondkommission on +46-40-615 14 10.